Lynch Syndrome Test System
Immunology · 21 CFR 864.1866
The Lynch syndrome test system is used to identify loss of DNA mismatch repair proteins or microsatellite instability in tumor tissue from cancer patients for the purpose of identifying patients who may benefit from additional testing for the inherited cancer predisposition Lynch Syndrome
Recent MDR events
4 adverse event reports on file
- BRAF V600E (VE1) MM PABMay 29, 2026MalfunctionVentana Medical Systems Inc.2028492-2026-02124
- PMS2 (A16-4) MM PABMay 6, 2026MalfunctionVentana Medical Systems Inc.2028492-2026-01766
- MLH1 (M1) MM PABMay 6, 2026MalfunctionVentana Medical Systems Inc.2028492-2026-01765
- CONFIRM ANTI-MSH6 (44) MOUSE MONOJun 19, 2019InjuryVentana Medical Systems2028492-2019-00012
Event type breakdown
Most-reported manufacturers
Recalls
0 recall events for this product code
No recalls on file for this product code.
Registered firms
6 firms currently registered for this product code
510(k) clearances
4 clearances for this product code
- Biocartis NVFeb 27, 2023
K211181 · Idylla MSI Test
- Leica Biosystems Newcastle, Ltd.Feb 21, 2023
K213348 · BOND MMR Antibody Panel
- Promega CorporationJul 26, 2021
K200129 · OncoMate MSI Dx Analysis System
- Ventana Medical SystemsOct 27, 2017
DEN170030 · VENTANA anti-MLH-1(M1) Mouse Monoclonal Primary Antibody, VENTANA anti-PMS2 (A16-4) Mouse Monoclonal Primary Antibody, VENTANA anti-MSH2 (G219-1129) Mouse Monoclonal Primary Antibody, VENTANA anti-MSH6 (SP 93) Mouse Monoclonal Primary Antibody, VENTANA anti-BRAF V600E (VE1) Mouse Monoclonal Primary Antibody